These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25390016)

  • 1. The pathophysiology of abdominal adipose tissue depots in health and disease.
    Walker GE; Marzullo P; Ricotti R; Bona G; Prodam F
    Horm Mol Biol Clin Investig; 2014 Jul; 19(1):57-74. PubMed ID: 25390016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors.
    Kranendonk ME; van Herwaarden JA; Stupkova T; de Jager W; Vink A; Moll FL; Kalkhoven E; Visseren FL
    Atherosclerosis; 2015 Apr; 239(2):419-27. PubMed ID: 25682042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.
    Lee MJ; Wu Y; Fried SK
    Mol Aspects Med; 2013 Feb; 34(1):1-11. PubMed ID: 23068073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M; Abate N
    J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic fat and cardiometabolic and vascular risk.
    Lim S; Meigs JB
    Int J Cardiol; 2013 Nov; 169(3):166-76. PubMed ID: 24063931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal obesity and cardiovascular risk: does waist circumference tell the story?
    Cardiovasc J S Afr; 2006; 17(4):215. PubMed ID: 17001430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Obesity in type 2 diabetes, its features and specificity].
    Xiang KS; Jia WP; Lu JX; Tang JL; Li J
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1768-72. PubMed ID: 15631769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity phenotypes: depot-differences in adipose tissue and their clinical implications.
    Guglielmi V; Sbraccia P
    Eat Weight Disord; 2018 Feb; 23(1):3-14. PubMed ID: 29230714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance].
    Hauner H
    Herz; 1995 Feb; 20(1):47-55. PubMed ID: 7713476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals.
    Targher G; Rossi AP; Zamboni GA; Fantin F; Antonioli A; Corzato F; Bambace C; Pozzi Mucelli R; Zamboni M
    J Endocrinol Invest; 2012 Sep; 35(8):748-53. PubMed ID: 21979274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal obesity and cardiovascular disease: is inflammation the missing link?
    Després JP
    Can J Cardiol; 2012; 28(6):642-52. PubMed ID: 22889821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance, adipose depots and gut: interactions and pathological implications.
    Gastaldelli A; Natali A; Vettor R; Corradini SG
    Dig Liver Dis; 2010 May; 42(5):310-9. PubMed ID: 20194050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
    Hajer GR; van Haeften TW; Visseren FL
    Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
    Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
    Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
    Hill JH; Solt C; Foster MT
    Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
    Lafontan M
    Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.